by arrayus_admin | Oct 2, 2024 | Press Releases
TORONTO, Oct 2, 2024—Arrayus Technologies Inc., a leader in innovative medical technology, is pleased to announce that its MRI-guided focused ultrasound system has been granted approval by Health Canada for the ablation of uterine fibroid tissue. Following the success...
by arrayus_admin | Sep 19, 2024 | Press Releases
TORONTO, Sept. 19, 2024- Bracco Imaging S.A., a global leader in diagnostic imaging, and Arrayus Technologies Inc., a medical device company committed to advancing novel cancer treatments have announced a new agreement. This collaboration will leverage Bracco...
by arrayus_admin | Jul 30, 2024 | Uncategorized
Arrayus’ non-invasive focused ultrasound therapy system was recently featured in CBC’s story on innovative treatments for women with uterine fibroids. We are proud to contribute to advancements in women’s health and work towards providing new therapy options for...
by arrayus_admin | Apr 12, 2024 | Uncategorized
Arrayus is pleased to announce that its founder, Dr. Kullervo Hynynen, has recently been inducted into the American Institute for Medical and Biological Engineering College of Fellows for his pioneering research in focused ultrasound (FUS). For more information, see:...
by arrayus_admin | Jan 20, 2023 | Press Releases
TORONTO, Jan. 18, 2023 /CNW/ – Arrayus Technologies Inc., an innovator in focused ultrasound therapy for oncology, announced today it has been awarded funding of up to $1.9 million from INOVAIT and the Government of Canada through the INOVAIT Focus Fund to...
